Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation
Ginkgo Bioworks (NYSE: DNA) has scheduled its Q4 and full year 2024 financial results presentation for Tuesday, February 25, 2025, at 5:30 p.m. ET. The presentation will include a business performance review and Q&A session.
Investors can access the presentation and webcast through Ginkgo's investor relations website, with a replay option available afterward. Questions can be submitted in advance via X (using #GinkgoResults) or email to investors@ginkgobioworks.com.
Ginkgo Bioworks (NYSE: DNA) ha programmato la presentazione dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per martedì 25 febbraio 2025, alle 17:30 ET. La presentazione includerà una revisione delle performance aziendali e una sessione di domande e risposte.
Gli investitori possono accedere alla presentazione e alla diretta streaming tramite il sito web delle relazioni con gli investitori di Ginkgo, con un'opzione di replay disponibile successivamente. Le domande possono essere inviate in anticipo tramite X (utilizzando #GinkgoResults) o via email a investors@ginkgobioworks.com.
Ginkgo Bioworks (NYSE: DNA) ha programado la presentación de sus resultados financieros del cuarto trimestre y del año completo 2024 para el martes 25 de febrero de 2025, a las 5:30 p.m. ET. La presentación incluirá una revisión del rendimiento empresarial y una sesión de preguntas y respuestas.
Los inversores pueden acceder a la presentación y la transmisión en vivo a través del sitio web de relaciones con inversores de Ginkgo, con una opción de repetición disponible posteriormente. Las preguntas se pueden enviar por adelantado a través de X (usando #GinkgoResults) o por correo electrónico a investors@ginkgobioworks.com.
Ginkgo Bioworks (NYSE: DNA)는 2025년 2월 25일 화요일 오후 5시 30분 ET에 2024년 4분기 및 연간 재무 결과 발표를 예정하고 있습니다. 발표에는 사업 성과 리뷰와 질의응답 세션이 포함될 것입니다.
투자자들은 Ginkgo의 투자자 관계 웹사이트를 통해 발표 및 웹캐스트에 접근할 수 있으며, 이후 재생 옵션도 제공됩니다. 질문은 X를 통해 미리 제출할 수 있으며 (#GinkgoResults 사용) 또는 이메일로 investors@ginkgobioworks.com으로 보낼 수 있습니다.
Ginkgo Bioworks (NYSE: DNA) a prévu la présentation de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour le mardi 25 février 2025, à 17h30 ET. La présentation comprendra un examen de la performance de l'entreprise et une session de questions-réponses.
Les investisseurs peuvent accéder à la présentation et au webinaire via le site web des relations avec les investisseurs de Ginkgo, avec une option de rediffusion disponible par la suite. Les questions peuvent être soumises à l'avance via X (en utilisant #GinkgoResults) ou par e-mail à investors@ginkgobioworks.com.
Ginkgo Bioworks (NYSE: DNA) hat die Präsentation der finanziellen Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 für Dienstag, den 25. Februar 2025, um 17:30 Uhr ET angesetzt. Die Präsentation wird eine Überprüfung der Unternehmensleistung und eine Frage-und-Antwort-Runde umfassen.
Investoren können über die Website für Investor Relations von Ginkgo auf die Präsentation und den Webcast zugreifen, mit einer Wiederholungsoption, die später verfügbar ist. Fragen können im Voraus über X (mit #GinkgoResults) oder per E-Mail an investors@ginkgobioworks.com eingereicht werden.
- None.
- None.
Presentation and Q&A session scheduled for post-market on Tuesday, February 25, 2025
The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
MEDIA CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-fourth-quarter-and-full-year-2024-results-presentation-302378620.html
SOURCE Ginkgo Bioworks
FAQ
When will Ginkgo Bioworks (DNA) release its Q4 2024 earnings?
How can investors access Ginkgo Bioworks' Q4 2024 earnings call?
How can investors submit questions for Ginkgo Bioworks' Q4 2024 earnings call?
Will there be a replay available for Ginkgo Bioworks' Q4 2024 earnings presentation?
